Discover and read the best of Twitter Threads about #thyrocare
Most recents (6)
Dr. Velumani onboard with 5% .
Aditya Puri inducted into the board and my guess will me made Chairman soon .
Founder( Siddharth Shah’s ) parents have tasted failure & succeeded.
FY22 Revenue : 6500 Cr.
Peak of Pessimism priced in ? Mostly.
#UL2
Aditya Puri inducted into the board and my guess will me made Chairman soon .
Founder( Siddharth Shah’s ) parents have tasted failure & succeeded.
FY22 Revenue : 6500 Cr.
Peak of Pessimism priced in ? Mostly.
#UL2
IPO only when it’s just 3-6 months away from hitting EBITDA Positive .
This one is a B2B + B2C + B2B2C bet .
Also it’s Diagnostics arm is smartly playing the Tier 3 & Tier 4 - BHARAT 🇮🇳 theme .
#Thyrocare #Pharmeasy
This one is a B2B + B2C + B2B2C bet .
Also it’s Diagnostics arm is smartly playing the Tier 3 & Tier 4 - BHARAT 🇮🇳 theme .
#Thyrocare #Pharmeasy
My Scuttlebutt revealed peak of TECH employee firing done by last December . Now realistic numbers have settled in .
Definitely 2022 has been a year of reevaluation ( maybe all thanks to Zomato, Nykaa & PolicyBazaars of the world)
$9 BN. to $6 BN. to where ? 😃
Definitely 2022 has been a year of reevaluation ( maybe all thanks to Zomato, Nykaa & PolicyBazaars of the world)
$9 BN. to $6 BN. to where ? 😃
The Heikin Ashi Trading Strategy !
A thread for Swing and Positional Traders who love Reversals !
Retweet And Share 🔄
@kuttrapali26 @AmitabhJha3
A thread for Swing and Positional Traders who love Reversals !
Retweet And Share 🔄
@kuttrapali26 @AmitabhJha3
What is Heikin Ashi ?
Go through this Tweet for complete understanding
1/n
Go through this Tweet for complete understanding
1/n
Tools used
1. HeikinAshi charts
2. 200 ema (black)for Dynamic support and reversal point
3. 21 ema(red) for trailing stop loss
4. Volumes
5. Your own confirmations and modification
2/n
1. HeikinAshi charts
2. 200 ema (black)for Dynamic support and reversal point
3. 21 ema(red) for trailing stop loss
4. Volumes
5. Your own confirmations and modification
2/n
Sharing 50+ colorful charts as I promised in this thread.
#Breakout stocks
#ASALCBR
#SPECIALITY
#KAMATH
#HCC
1/n
#Breakout stocks
#ASALCBR
#SPECIALITY
#KAMATH
#HCC
1/n
#Pharmeasy - Health Tech #unicorn – to acquire Majority stake (66%) in #Thyrocare. Open offer for an additional 26% stake at Rs1300/sh. With this diagnostics bet, it completes its exhaustive portfolio of "Wholistic Outpatient Healthcare Ecosystem". (1/9)
Gujju Gang from Ghatkopar (as founders call themselves) make it big in what is first-ever acquisition of publicly listed firm by the unicorn. New funding tied up at #valuations of USD4bn. Promoters of Thyrocare will also be investing in Pharmeasy for 5% stake. (2/9)
Pharmeasy founders started as venture called dialhealth.com (2012-13) which failed, followed by Dial Health chain of retail stores which also failed. After 2 failed ventures, they moved to distribution business (& B2B) that was a success (2015). (3/9)
Indian Diagnostic industry is ~USD 9bn; expected to grow at 10% CAGR over next 5years
edelweiss.in/research/secto…
@EdelweissWM @MetroHealthLab @drlalpathlabs #indiandiagnostic #Indianhealthcare #diagnostics #healthcare
edelweiss.in/research/secto…
@EdelweissWM @MetroHealthLab @drlalpathlabs #indiandiagnostic #Indianhealthcare #diagnostics #healthcare
Refferrals still constitute major part in diagnostic sector
National Diagnostics chains outperform the sector: 21% sales CAGR over last ten years #diagnostics #metropolishealthcare #drlalpathlabs
Did a 11 years #dataanalysis to find out what are some of the well known brands that has gone for #IPO and what would have been the returns if we have bought them on listing day instead of IPO, and hold onto it for a month. #IRCTC #ipoinvestment #investment #nifty #stockstowatch
And here's the list of IPOs and its monthly returns sorted based on recent listing period. #INDIGO #DMART #RBLBANK #INDIAMART #PNB #CDSL #THYROCARE
The detailed article can be accessed from this link squareoff.in/single-post/Bi…
